June 2026
You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get StartedGuangzhou Anbiping Pharm... Market Share Analysis for June 2026
广州安必平医药科技股份有限公司（股票代码：688393）专注于肿瘤筛查与诊断，自主研发了一系列肿瘤筛查及诊断试剂与配套设备，主要应用科室为病理科。目前已搭建液基细胞学（lbp）、聚合酶链式反应（pcr）、免疫组织化学（ihc）和荧光原位杂交（fish）四大系列产品线，涵盖肿瘤筛查与诊断从细胞形态到蛋白表达、基因检测等不同诊断层次的临床需求，部分产品获得ce欧盟、英国标准协会（bsi）、日本厚生劳动省的认证，系国内肿瘤筛查及诊断行业内技术平台最丰富、产品种类最多的企业之一。
Industry: N/A
Guangzhou Anbiping Pharmaceutical Tec... (including company regionals)
See more website traffic and engagement information- gzlbp.com
Guangzhou Anbiping Pharmaceutical Tec... Revenue up to June 2026 is 2M - 5M
revenue generated by Guangzhou Anbiping Pharmaceutical Tec... top domains
Guangzhou Anbiping Pharmaceutical Tec... top domains revenue over 3 years
Revenue for Guangzhou Anbiping Pharmaceutical Tec... top domains
Total visits to Guangzhou Anbiping Pharmaceutical Tec...'s top domains
Understand Guangzhou Anbiping Pharmaceutical Tec... market share and potential market reach.
Total visits last 3 months
Subsidiaries Breakdown
Avg. visit duration in Guangzhou Anbiping Pharmaceutical Tec...'s top domains
Analyze Guangzhou Anbiping Pharmaceutical Tec... engagement metrics.
Average visit duration last 3 months
Avg. pageviews on Guangzhou Anbiping Pharmaceutical Tec...'s top domains
See how Guangzhou Anbiping Pharmaceutical Tec... keep users engaged, nurture their interest, and encourage them to take the next step.
Average page views last 3 months
Subsidiaries Breakdown
